Navigation Links
GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI)
Date:3/7/2012

r ability to raise anti-HIV humoral (antibody) and cellular (cytotoxic T cell) immune responses, as well as, the vaccines' safety. Successful results from Phase 1 testing supported Phase 2 testing in an ongoing, fully enrolled, 299 participant trial in North and South America . GeoVax is also enrolling volunteers in a Phase 1/2 therapeutic trial for individuals already infected with HIV. For more information, please visit www.geovax.com.

Forward-Looking Statements
Certain statements in this document are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax can develop and manufacture its vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective or easier to use than GeoVax's products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. More information about these factors is contained in GeoVax's filings with the Securities and Exchange Commission including those set forth at "Risk Factors" in GeoVax's Form 10-K.

Contact

IRG, LLC:
Erika Moran , Investor Relations
Janet Vasquez , Public Relations
(212) 825-3210

 


'/>"/>
SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
2. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
3. GeoVax Presents Data at AIDS Vaccine 2008 Conference
4. GeoVaxs DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
5. GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
6. GeoVax to Present at the BIO CEO & Investor Conference 2009
7. GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference
8. GeoVax Update Provided at the BIO CEO & Investor Conference 2009
9. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
10. GeoVax Labs, Inc. Announces First Quarter Financial Results
11. GeoVax to Exhibit at the 2009 BIO International Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... a world-leading provider of scientific, technical and medical information ... recent study in Reproductive BioMedicine Online ... with an abnormal chromosomal composition can be identified by ... thereby classifying the risk of genetic abnormality without a ... undertaken a retrospective study, using their predictive model to ...
(Date:5/17/2013)... , May 17, 2013 ... by the most innovative thought leaders of the ... & Manufacturing East conference and expo, from June ...      (Photo: http://photos.prnewswire.com/prnh/20130517/613829 ) , ... designed to deliver industry professionals practical presentations and ...
(Date:5/17/2013)... JOSE, Calif. , May 17, 2013 /PRNewswire-iReach/ ... agreement has been reached with Switzerland ... portfolio of anti-infective human monoclonal antibody (mAb) products, ... anti-infective human mAb products for treatment of infections ... of Staphylococcus aureus , Pseudomonas aeruginosa ...
(Date:5/17/2013)... 2013 The paradigm of ‘one drug, ... that can help predict the adverse and therapeutic effects ... Head of Computational Biology at the Genomics Laboratory, Covance, ... ensure high-quality genomics when used as part of the ... complex data sets to identify key clinical targets even ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3
... Close Completes $35 Million Financing, WOBURN, Mass., Nov. ... generation biologics for the treatment and,prevention of cancer and ... financing, concurrent with the completion of a,venture debt transaction, ... intends to use the capital to complete its preparations ...
... for,U-Md. Bioscience Day, COLLEGE PARK, Md., Nov. 14 ... technology enabling him to develop an,infinite variety of safe, ... capitalists and the title of "Best Inventor Pitch" at ... university,s Office of Technology Commercialization,the College of Chemical and ...
... Inc. (Nasdaq: ADLS ), a biopharmaceutical company ... drugs in the,therapeutic areas of infection, cancer and ... third quarter ended September 30,2007. (Logo: ... three months ended September 30, 2007 was $5.8,million ...
Cached Biology Technology:BioVex Closes Second Round of Series E Financing 2Pure Plastics Pitch Proves Perfect 2Pure Plastics Pitch Proves Perfect 3Advanced Life Sciences Announces Third Quarter 2007 Financial Results 2Advanced Life Sciences Announces Third Quarter 2007 Financial Results 3Advanced Life Sciences Announces Third Quarter 2007 Financial Results 4Advanced Life Sciences Announces Third Quarter 2007 Financial Results 5Advanced Life Sciences Announces Third Quarter 2007 Financial Results 6Advanced Life Sciences Announces Third Quarter 2007 Financial Results 7Advanced Life Sciences Announces Third Quarter 2007 Financial Results 8Advanced Life Sciences Announces Third Quarter 2007 Financial Results 9
(Date:5/16/2013)... Infections can trigger hematopoiesis at sites outside the bone ... skin.Researchers of Ludwig-Maximilians-Universitaet (LMU) in Munich now show that ... medullary" formation of blood cells. , Balanced hematopoiesis is ... fetal development, hematopoiesis takes place mainly in the liver ... the bone marrow, and this tissue normally serves as ...
(Date:5/16/2013)... the gym. But doctors use the human pulse as a ... professor of chemical engineering at Stanford, has developed a heart ... a postage stamp. The flexible skin-like monitor, worn under an ... doctors detect stiff arteries and cardiovascular problems. , The devices ... and provide doctors a safer method of measuring a key ...
(Date:5/15/2013)... that have powerful behavioral effects on diverse organisms ... ecosystems, according to a theory proposed in the ... of the theory, Ryan P. Ferrer of Seattle ... University of California at Los Angeles, liken such ... may be uncommon but exert a controlling influence, ...
Breaking Biology News(10 mins):Herpes infections: Natural killer cells activate hematopoiesis 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3Natural 'keystone molecules' punch over their weight in ecosystems 2
... has chosen Springer to publish its official journal, ... be published at Springer in April 2009. The ... Science International focuses on the morphological sciences in ... and gross anatomical studies. In addition to original ...
... 16, 2009--Throughout the world, nitrogen compounds are released ... of fossil fuels. These pollutants are deposited to ... hundreds of miles downwind of their release point. ... a case in pointthough they contain little in ...
... Planting soybean on the optimum date produces maximum yield and ... is hard to indentify, because it varies from year to ... and when it rains. "Planting date has been ... into the United States, so there is a large database ...
Cached Biology News:Anatomical Science International joins Springer's publishing program 2Tree species composition influences nitrogen loss from forests 2No consistent advantage for planting soybean early 2
... Magnetofection technology, SilenceMag is the most ... rapid and easy to use, SilenceMag ... Specifically designed for siRNA delivery, SilenceMag ... low doses of siRNA.,SilenceMag formulation gives ...
... Purity is >95%NEN Radiolabeled Ligands\n\nReceptor-related research has ... of new radiolabeled ligands selected to keep ... wide range of products and services for ... 400 state-of-the-art radioligands. If you do not ...
... Test Plate consists of an anodized aluminum ... Organic Fluorescent Compounds embedded in polymerized matrix. ... BioTeks FLx800 and Synergy Multi-Detection Readers. This ... compliance while reducing the need for tedious ...
... Feature Extraction Software reads ... files to prepare microarray data ... , * one 2-year ... for NFP/Academic accounts , * ...
Biology Products: